Table 1 Validation cohort of 3’ UTR Apobec-1 RNA targets
| Â | Â | Â | Â | Â | Rosenberg et al.[16] | Â | Current | Â | Â | |
|---|---|---|---|---|---|---|---|---|---|---|
| Â | RNA | Chr | Position | Reference base | Editing frequency | Sanger | RNA-seq | Reads | Sanger | Edited/total |
1. | Sult1d1 | 5 | 87984364 (-) | G | 79% | 82% | 92% | 26 | 91% | (20/22) |
2. | Mfsd7b | 1 | 192830761 (-) | G | 78% | Â | 78% | 148 | 50% | (10/20) |
3. | Aldh6a1 | 12 | 85772761 (-) | G | 56% | Â | 68% | 38 | 50% | (10/20) |
4. | Usp25 | 16 | 77116537 (+) | C | 50% | Â | 68% | 44 | 58% | (11/19) |
5. | Serinc1 | 10 | 57235791 (-) | G | 75% | Â | 66% | 50 | 60% | (12/20) |
6. | Tmem30a | 9 | 79617629 (-) | G | 55% | Â | 65% | 29 | 61% | (11/18) |
7. | Bche | 3 | 73442586 (-) | G | 36% | Â | 61% | 52 | 64% | (14/22) |
8. | 2010106E10Rik | X | 109671648 (+) | C | 46% | Â | 61% | 544 | 54% | (12/22) |
9. | Gramd1c | 16 | 43981376 (-) | G | 29% | Â | 59% | 68 | 68% | (13/19) |
10. | Cmtm6 | 9 | 114658289 (+) | C | nd | Â | 54% | 305 | 75% | (15/20) |
11. | BC013529 | 1 | 152209582 (-) | G | 45% | Â | 50% | 35 | 40% | (8/20) |
12. | Cyp4v3 | 8 | 46391931 (-) | G | 38% | 36% | 49% | 3381 | 29% | (5/17) |
13. | Sh3bgrl | X | 106355759 (+) | C | 30% | 20% | 43% | 70 | 40% | (8/20) |
14. | Clic5 | 17 | 44416335 (+) | C | 31% | Â | 37% | 1243 | 23% | (5/22) |
15. | App | 16 | 84954758 (-) | G | 21% | Â | 34% | 221 | 4% | (1/22) |
| Â | App | 16 | 84955113 (-) | G | 21% | Â | 30% | 1539 | 21% | (4/19) |
16. | Hprt1 | X | 50374459 (+) | C | 22% | Â | 31% | 168 | 20% | (4/20) |
17. | B2m | 2 | 121978638 (+) | C | 18% | Â | 28% | 803 | 27% | (6/22) |
18. | Tmbim6 | 15 | 99239051 (+) | C | 20% | Â | 24% | 1145 | 30% | (6/20) |
19. | Rnf128 | X | 136207009 (+) | C | 20% | Â | 24% | 779 | 18% | (4/22) |
20. | Rrbp1 | 2 | 143811725 (-) | G | 38% | Â | 22% | 269 | 5% | (1/20) |
21. | Sep15 | 3 | 144259976 (+) | C | 54% | 15% | 14% | 738 | 23% | (5/22) |
22. | Ank3 | 10 | 69486962 (+) | C | 36% | Â | 13% | 400 | 5% | (1/21) |
23. | Lrrc19 | 4 | 94304303 (-) | G | 26% | Â | 11% | 26 | 4% | (1/22) |